Clinical Trial Update: Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety, pharmacokinetics, and anti-inflammatory effects of CC10 protein in premature infants with respiratory distress syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome

Drugs mentioned

• CC10 Protein (CC10 protein)

Snippet

Sponsor: Clarassance, Inc. | Conditions: Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia | Phase 1, Phase 2 | Status: COMPLETED